Abivax S.A.
Abivax S.A. (ABVX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
abvx · stock forecast · 12 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 12 Wall Street analysts in the past 3 months
Buy
12 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$175
Consensus
$131
+26.0% upside
Low
$90.00
Median: $135 · Last Close: $104.11
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$131.22
26.0% upside
High Target
$175
68.1%
Low Target
$90
-13.6%
Current Price
$104.11
as of today
Based on analyst price targets, the ABVX stock price prediction for the next 12 months ranges from $90 to $175. The consensus ABVX price forecast of $131.22 implies 26.0% upside from the current price of $104.11.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $104.11 | ↑ 0.00% |
1-day model range: $101.29–$106.93. Peak: $106.93 (+0.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ABVX · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-02 | Truist Securities | Maintains | Buy→Buy |
| 2026-06-02 | Jefferies | Downgrade ↓ | Buy→Hold |
| 2026-06-02 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2026-06-02 | Wedbush | Upgrade ↑ | Underperform→Neutral |
| 2026-06-02 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-06-02 | BTIG | Maintains | Buy→Buy |
| 2026-05-26 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-03-24 | Barclays | Maintains | Overweight→Overweight |
| 2026-02-25 | BTIG | Maintains | Buy→Buy |
| 2026-01-09 | Morgan Stanley | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Abivax S.A. (ABVX) stock. Of the recent 27 rating actions, 2 were upgrades and 1 were downgrades. 12 analysts currently cover ABVX.
Analyst Recommendation Trends
ABVX analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 4 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$71M
↓ 84.5% YoY
Revenue Next Year
$114M
↑ 61.5% YoY
EPS This Year
$-3.43
EPS Next Year
$-3.05
↓ 11.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast ABVX EPS of $-3.43 for the current fiscal year, based on estimates from 4 analysts. The ABVX revenue forecast is $71M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ABVX stock forecast is supported by two independent data sources: analyst consensus ratings from 12 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ABVX price target is $131.22 (+26.0% upside), with an analyst consensus of Buy.
The ABVX short-term stock prediction for tomorrow is $104.11 (+0.00%).
Abivax S.A. trades on NASDAQ under the ticker ABVX. The ABVX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 83% of covering analysts.
Frequently asked questions
ABVX forecast · 8 questionsAccording to 12 Wall Street analysts, the average 12-month ABVX price target is $131.22, with a high forecast of $175.00 and a low of $90.00. The median price target is shown in the chart above when available. This implies +26.0% potential upside from the current price of $104.11.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.